ABBOTT LABORATORIES - 10-Q Filing
Abbott Laboratories reports Q3 2026 financial results with segment performance across Medical Devices, Diagnostic Products, Nutritional Products, and Established Pharmaceutical Products. (Items: 8.01 of its Current Report on Form 8-K filed on August 20, 2026, including those described below (as of September 30, 2026, except where noted bel)
Tickers: $ABT